Antinociceptive mechanism of the spirocyclopiperazinium compound LXM-10 in mice and rats

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 2, 2010, Pages 192-197

  Xiong, Yulan ^a,c   Zhao, Xia ^b   Sun, Qi ^b   Li, Runtao ^b   Li, Changling ^b   Ye, Jia ^a,b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY SIXTH HOSPITAL   (China)

Author keywords

7 Nicotinic acetylcholine receptor; Antinociception; LXM 10; M4 muscarine acetylcholine receptor

Indexed keywords

2,4 DIMETHYL 9 BETA PHENYLETHYL 3 OXO 6,9 DIAZASPIRO[5.5]UNDECANE CHLORIDE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ANTINOCICEPTIVE AGENT; ATROPINE METHYL NITRATE; BICUCULLINE; BUNGAROTOXIN RECEPTOR; HEXAMETHONIUM; LXM 10; METHYLLYCACONITINE; METHYLLYCACONITINE CITRATE; MUSCARINIC RECEPTOR; PHACLOFEN; TROPICAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FEMALE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANALGESICS; ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C57BL; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SPIRO COMPOUNDS;

MUS; RATTUS;

EID: 76949086441     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.01.004     Document Type: Article

References (34)

1. Badio B., and Daly J.W. Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol 45 4 (1994) 563-569
2. Beirith A., Santos A.R., Rodrigues A.L., Creczynski-Pasa T.B., and Calixto J.B. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur J Pharmacol 345 3 (1998) 233-245
3. Bhave G., Karim F., Carlton S.M., and Gereau R.T. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 4 4 (2001) 417-423
4. Boccia M.M., Acosta G.B., and Baratti C.M. Memory improving actions of gabapentin in mice: possible involvement of central muscarinic cholinergic mechanism. Neurosci Lett 311 3 (2001) 153-156
5. Caulfield M.P. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 58 3 (1993) 319-379
6. Damaj M.I., Meyer E.M., and Martin B.R. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology 39 13 (2000) 2785-2791
7. Davies A.R.L., Hardick D.J., Blagbrough I.S., Potter B.V.L., Wolstenholme A.J., and Wonnacott S. Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38 5 (1999) 679-690
8. Decker M.W., Bannon A.W., Buckley M.J., Kim D.J., Holladay M.W., Ryther K.B., et al. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. Eur J Pharmacol 346 1 (1998) 23-33
9. Dussor G.O., Helesic G., Hargreaves K.M., and Flores C.M. Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron. Pain 107 1-2 (2004) 22-32
10. Duttaroy A., Gomeza J., Gan J.W., Siddiqui N., Basile A.S., Harman W.D., et al. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 62 5 (2002) 1084-1093
11. Ehlert F.J., and Tran L.P. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. J Pharmacol Exp Ther 255 3 (1990) 1148-1157
12. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., and Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383 6602 (1996) 713-716
13. Haberberger R.V., Bernardini N., Kress M., Hartmann P., Lips K.S., and Kummer W. Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat. Autonom Neurosci 113 (2007) 32-42
14. Hama A.T., Lloyd G.K., and Menzaghi F. The antinociceptive effect of intrathecal administration of epibatidine with clonidine or neostigmine in the formalin test in rats. Pain 91 4 (2001) 131-138
15. Hamurtekin E., and Gurun M.S. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system. Brain Res 1117 1 (2006) 92-100
16. Jones P.G., and Dunlop J. Targeting the cholinergic system as a therapeutic strategy for the treatment of pain. Neuropharmacology 53 2 (2007) 197-206
17. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73 2 (1997) 123-139
18. Li D.P., Chen S.R., Pan Y.Z., Levey A.I., and Pan H.L. Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol 543 Pt 3 (2002) 807-818
19. Maggi L., Sher E., and Cherubini E. Regulation of GABA release by nicotinic acetylcholine receptors in the neonatal rat hippocampus. J Physiol 536 Pt 1 (2001) 89-100
20. Millan M.J. Descending control of pain. Prog Neurobiol 66 6 (2002) 355-474
21. Mulugeta E., El-Bakri N., Karlsson E., Elhassan A., and Adem A. Loss of muscarinic M4 receptors in spinal cord of arthritic rats: implications for a role of M4 receptors in pain response. Brain Res 982 2 (2003) 284-287
22. Nathanson N.M. Synthesis, trafficking, and localization of muscarinic acetylcholine receptors. Pharmacol Ther 119 1 (2008) 33-43
23. O'Callaghan J.P., and Holtzman S.G. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J Pharmacol Exp Ther 192 3 (1975) 497-505
24. Patel S., Naeem S., Kesingland A., Froestl W., Capogna M., Urban L., et al. The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90 3 (2001) 217-226
25. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 429 1-3 (2001) 79-91
26. Sawynok J. GABAergic mechanisms of analgesia: an update. Pharmacol Biochem Behav 26 2 (1987) 463-474
27. Sun Q., Yue C., Ye J., Li C., Cheng T., and Li R. Unique spirocyclopiperazinium salt III: further investigation of monospirocyclopiperazinium (MSPZ) salts as potential analgesics. Bioorg Med Chem Lett 17 22 (2007) 6245-6249
28. Vogt K.E., and Regehr W.G. Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus. J Neurosci 21 1 (2001) 75-83
29. Wang Y., Su D.M., Wang R.H., Liu Y., and Wang H. Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 132 1 (2005) 49-56
30. Wess J., Duttaroy A., Gomeza J., Zhang W., Yamada M., Felder C.C., et al. Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review. Life Sci 72 18-19 (2003) 2047-2054
31. Yue C.Q., Ye J., Li C.L., Li R.T., and Sun Q. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice. Pharmacol Biochem Behav 86 4 (2007) 643-650
32. Zhang H.M., Li D.P., Chen S.R., and Pan H.L. M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons. J Pharmacol Exp Ther 313 2 (2005) 697-704
33. Zhang H.M., Chen S.R., and Pan H.L. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes. J Neurophysiol 97 1 (2007) 102-109
34. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 2 (1983) 109-110